Buy Sermorelin & GHRP-6 Blend – Advanced Growth Hormone Research Peptide
The Sermorelin & GHRP-6 peptide blend is a powerful combination designed for laboratory research on growth hormone (GH) release. These synthetic peptides target pituitary cells through distinct receptors, offering a synergistic stimulus that may enhance GH secretion compared to either peptide alone.
If you’re exploring growth hormone peptides for research, this blend represents a unique tool to study somatotroph activation. Sermorelin, an analog of endogenous Growth Hormone-Releasing Hormone (GHRH), activates classical GHRH receptors, stimulating cAMP-linked pathways that support GH synthesis and release. GHRP-6, a growth hormone secretagogue, targets ghrelin-sensitive receptors (GHS-R1a), activating alternative signaling pathways to mobilize GH-containing vesicles.
How the Blend Works
Individually, Sermorelin and GHRP-6 stimulate GH release via complementary mechanisms. Together, they may provide a more robust response in pituitary cells:
- Sermorelin: Mimics GHRH, engaging classical GHRH receptors, activating PKA signaling, and promoting GH release.
- GHRP-6: Targets GHS-R1a receptors, triggering PLC, IP₃, DAG, and PKC pathways, further enhancing GH secretion.
- Synergistic Effect: Research indicates the combination can potentially double GH release compared to GHRP-6 alone, highlighting the blend’s lab-focused research advantages.
Research Highlights
- Sermorelin exposure increased 12-hour mean GH concentrations from ~1.1 µg/L to ~2.2 µg/L.
- GHRP-6 alone can trigger GH peaks up to 50-fold above baseline.
- Combined, the blend may achieve a total GH peak 2–3 times higher than individual peptides in experimental models.
- The blend may also influence downstream markers like IGF-1 and IGFBP-3, critical in GH signaling research.
Benefits in Research
- Enables enhanced GH release studies
- Useful for experiments on somatotroph activity and pituitary function
- Provides insight into synergistic peptide interactions
- Supports laboratory exploration of IGF-1 signaling and growth hormone pathways
Chemical Profile
- Sermorelin: GRF 1-29 NH₂, Molecular Weight 93 g/mol, Formula C₁₄₉H₂₄₆N₄₄O₄₂S
- GHRP-6: SKF-110679, Molecular Weight 603 g/mol, Formula C₄₆H₅₆N₁₂O₆
Important Notice
This blend is intended strictly for laboratory research and experimental purposes. It is not approved for human use. Handle under proper research protocols.



